{"id":649924,"date":"2023-05-01T18:00:02","date_gmt":"2023-05-01T18:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=649924"},"modified":"2023-05-01T18:00:02","modified_gmt":"2023-05-01T18:00:02","slug":"psoriasis-market-analysis-market-size-epidemiology-leading-companies-companies-eli-lilly-and-company-ucb-pharma-akros-pharma-kadmon-pharmaceuticals-dermavant","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/psoriasis-market-analysis-market-size-epidemiology-leading-companies-companies-eli-lilly-and-company-ucb-pharma-akros-pharma-kadmon-pharmaceuticals-dermavant_649924.html","title":{"rendered":"Psoriasis Market Analysis, Market Size, Epidemiology, Leading Companies | Companies – Eli Lilly and Company, UCB Pharma, Akros Pharma, Kadmon Pharmaceuticals, Dermavant"},"content":{"rendered":"
\n
\"Psoriasis<\/a><\/div>\n
\n
Psoriasis Market<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Psoriasis – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight has launched a new report on “Psoriasis – Market Insights, Epidemiology, and Market Forecast-2032”.<\/strong><\/p>\n

DelveInsight’s “Psoriasis – Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>″ report deliver an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Psoriasis Market Report<\/a>:<\/strong><\/p>\n

    \n
  1. According to a research study, up to 40 % of patients with psoriasis go on to develop PsA, usually within 5-10 years of cutaneous disease onset.<\/li>\n
  2. The study reported the incidence of psoriasis in all ages, with the incidence of the disease varying from 31.4 per 100 000 person-years in eastern Europe (Russia) to 521.1 per 100 000 person-years in western Europe (Germany).<\/li>\n
  3. According to a study, psoriasis Vulgaris represents 90% of cases, psoriasis arthropathic around 4%, followed by guttate type psoriasis (3%), psoriatic erythroderma (1%), and generalized pustular psoriasis (1%) in Japan.<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

      \n
    1. Psoriasis market report covers a descriptive overview and comprehensive insight of the Psoriasis Epidemiology and Psoriasis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/li>\n
    2. The Psoriasis market report provides insights on the current and emerging therapies.<\/li>\n
    3. Psoriasis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n
    4. The Psoriasis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Psoriasis market.<\/li>\n<\/ol>\n

      Got queries? Click here to know more about Psoriasis Market Landscape<\/a>.<\/strong><\/p>\n

      Psoriasis Overview<\/strong><\/p>\n

      Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas. <\/p>\n

      The key players involved in the Psoriasis market<\/a>:<\/strong><\/p>\n